VITROS IMMUNODIAGNOSTIC PRODUCTS MYOGLOBIN REAGENT PACK 6801042

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-02-06 for VITROS IMMUNODIAGNOSTIC PRODUCTS MYOGLOBIN REAGENT PACK 6801042 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[138166854] The investigation confirmed that a lower than expected vitros myoglobin (myog) result was obtained from a cliniqa quality control (qc) fluid processed using vitros myog reagent in combination with a vitros 5600 integrated system. The investigation was unable to determine a definitive assignable cause. However, a possible cause for the lower than expected qc fluid result is a suboptimal calibration event. Qc performance improved after another calibration event was executed. In addition, per a customer communication issued 28 november 2018, calibrators must be left out for a minimum of two hours following reconstitution prior to calibrating. Because the customer could not confirm this protocol was initially followed, pre-analytical fluid handling cannot be ruled out as a cause of this event. The vitros 5600 integrated system was performing as intended and did not likely contribute to the event as within-run precision testing performed by the customer was within acceptable guidelines. Additionally, a reagent issue is not a likely cause of the event as a different vitros 5600 integrated system is running as expected when using the same vitros myog reagent lot. Furthermore, continual tracking and trending of complaints has not identified any signals that show a potential systemic issue with vitros myog reagent lot 1390.
Patient Sequence No: 1, Text Type: N, H10


[138166855] A customer reported a lower than expected result from a cliniqa quality control (qc) fluid obtained using vitros immunodiagnostics products myoglobin (myog) reagent on a vitros 5600 integrated system. Cliniqa lot 1804042 (l1) vitros myog result of 51. 5 ng/ml vs an expected result of 65. 1 ng/ml biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples. The unexpected vitros myog result was generated from a qc fluid. However, the investigation could not conclude that patient sample results were not affected or would not be affected if the event were to recur undetected. There was no allegation of patient harm as a result of the event. This report corresponds to ortho clinical diagnostics inc. Complaint number (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007111389-2019-00025
MDR Report Key8313163
Date Received2019-02-06
Date of Report2019-02-06
Date of Event2019-01-13
Date Mfgr Received2019-01-13
Device Manufacturer Date2018-09-04
Date Added to Maude2019-02-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO CLINICAL DIAGNOSTICS
Manufacturer StreetFELINDRE MEADOWS PENCOED
Manufacturer CityBRIDGEND, WALES CF355PZ
Manufacturer CountryUK
Manufacturer Postal CodeCF35 5PZ
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS IMMUNODIAGNOSTIC PRODUCTS MYOGLOBIN REAGENT PACK
Generic NameIN VITRO DIAGNOSTICS
Product CodeDDR
Date Received2019-02-06
Catalog Number6801042
Lot Number1390
Device Expiration Date2019-08-07
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2019-02-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.